Intratumoral lymphatics are essential for the metastatic spread and prognosis in squamous cell carcinomas of the head and neck region

被引:0
|
作者
Maula, SM
Luukkaa, M
Grénman, R
Jackson, D
Jalkanen, S
Ristamäki, R
机构
[1] Turku Univ, MediCity Res Labs, FIN-20520 Turku, Finland
[2] Turku Univ, Sch Biomed Sci, Natl Publ Hlth Inst, Dept Med Microbiol, FIN-20520 Turku, Finland
[3] Turku Univ, Cent Hosp, Dept Radiotherapy & Oncol, FIN-20520 Turku, Finland
[4] Turku Univ, Cent Hosp, Dept Otorhinolaryngol Head & Neck Surg, FIN-20520 Turku, Finland
[5] John Radcliffe Hosp, Inst Mol Med, MRC, Human Immunol Unit, Oxford OX3 9DS, England
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Head and neck squamous cell carcinomas (HNSCCs) frequently disseminate to regional lymph nodes. To investigate the possible mechanisms involved, we studied the expression of cancer cell adhesion molecules together with lymphatic vascular and blood vascular markers in a panel of 97 primary HNSCC tumors and correlated expression levels with conventional clinicopathological parameters and with long-term prognosis. In particular, we measured the density of intratumoral and peritumoral lymph vessels as assessed with the marker lymphatic vessel endothelial hyaluronan receptor 1 (LYVE-1) and the density of tumor CD44, a receptor up-regulated in many metastatic cancers. Intratumoral LYVE-1(+) lymphatic vessels were clearly associated with a higher risk for local relapse as well as with poor disease-specific prognosis (P = 0.02 and 0.0009, respectively). In contrast, a high density of peritumoral LYVE-1(+) vessels was a sign of favorable survival (P = 0.05). Strong primary tumor CD44 expression was associated with a poor prognosis, an increased risk of local recurrence (P = 0.03 and 0.02, respectively), and an increase in resistance to radiation therapy (P = 0.03). CD44 was the only factor with an independent prognostic value for the disease-specific overall survival (P = 0.04). Our results suggest that intratumoral lymphatics play a greater role than peritumoral lymphatics in nodal metastasis of HNSCC and that tumor CD44 levels can predict sensitivity to radiation therapy. These parameters may be useful predictive and prognostic tools in the clinical management of HNSCC.
引用
收藏
页码:1920 / 1926
页数:7
相关论文
共 50 条
  • [1] Management of metastatic head and neck squamous cell carcinomas
    Saada, E.
    Ferrand, F. -R.
    Peyrade, F.
    Guigay, J.
    ONCOLOGIE, 2015, 17 (5-6) : 245 - 249
  • [2] Correspondence re:: S.!Maula et al., Intratumoral lymphatics are essential for the metastatic spread and prognosis in squamous cell carcinoma of the head and neck. cancer res., 63: 1920-1926, 2003.
    Padera, TP
    Boucher, Y
    Jain, RK
    CANCER RESEARCH, 2003, 63 (23) : 8555 - 8556
  • [3] CELLULAR DNA AMOUNTS OF SQUAMOUS-CELL CARCINOMAS OF THE HEAD AND NECK REGION IN RELATION TO PROGNOSIS
    HOLM, LE
    LARYNGOSCOPE, 1982, 92 (09): : 1064 - 1069
  • [4] An epidemiological study of squamous cell carcinomas of head and neck region
    Kurtulmaz, S
    Erkal, HS
    Serin, M
    Cakmak, A
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 439 - 439
  • [5] Lateralization of squamous cell carcinomas in the head-neck region
    Dane, S
    Karasen, M
    Sahin, Ö
    Öztop, E
    PERCEPTUAL AND MOTOR SKILLS, 2005, 100 (01) : 258 - 262
  • [6] A REVIEW OF EPIDEMIOLOGY, PROGNOSIS, AND TREATMENT OPTIONS FOR RECURRENT OR METASTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMAS (HNSCC)
    Blieden, M.
    Muszbek, N.
    Chaudhary, M. A.
    Zhang, Y.
    VALUE IN HEALTH, 2017, 20 (05) : A94 - A94
  • [7] The Impact of Intratumoral Heterogeneity Parameters on Prognosis in Head and Neck Squamous Cell Carcinoma
    Mladkova, N.
    Baliga, S.
    Mitchell, D. L.
    Jhawar, S. R.
    Grecula, J. C.
    Gamez, M. E.
    Blakaj, D. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E545 - E545
  • [8] Correspondence re:: S.!Maula et al., intratumoral lymphatics are essential for the metastatic spread and prognosis in squamous cell carcinoma of the head and neck. cancer res., 63: 1920-1926, 2003.: Reply
    Wein, LM
    Holden, PE
    Kirn, DH
    CANCER RESEARCH, 2003, 63 (23) : 8556 - 8557
  • [9] SQUAMOUS CARCINOMAS OF THE HEAD AND NECK - SOME PATTERNS OF SPREAD
    CARTER, RL
    PITTAM, MR
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 1980, 73 (06) : 420 - 427
  • [10] Squamous cell carcinomas of the head and neck
    Sanderson, RJ
    Ironside, JAD
    BMJ-BRITISH MEDICAL JOURNAL, 2002, 325 (7368): : 822 - 827